Skip to main content

Nurix Therapeutics, Inc.

NRIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001549595

In the last 90 days, Nurix Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 211 institutions reported holding it in 13F filings for Q2 2026, worth $2.84B in total; ARK Invest is the only superinvestor holding it.

13F holders, Q1 2023

Institutional positions in Nurix Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
124
+5 vs. Q4 2022
Shares held
42.5M
−197.1K (−0.5%) vs. Q4 2022
Total value
$376.6M
−$92.0M (−19.6%) vs. Q4 2022
New holders
18
45 more added
Sold out
13
37 more reduced

Compare with Q4 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting NRIX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2023: 124 institutions
Q1 2021: 101 institutionsQ2 2021: 104 institutionsQ3 2021: 113 institutionsQ4 2021: 125 institutionsQ1 2022: 117 institutionsQ2 2022: 106 institutionsQ3 2022: 118 institutionsQ4 2022: 119 institutionsQ1 2023: 124 institutionsQ2 2023: 126 institutionsQ3 2023: 129 institutionsQ4 2023: 131 institutionsQ1 2024: 139 institutionsQ2 2024: 174 institutionsQ3 2024: 172 institutionsQ4 2024: 175 institutionsQ1 2025: 170 institutionsQ2 2025: 164 institutionsQ3 2025: 173 institutionsQ4 2025: 182 institutionsQ1 2026: 196 institutionsQ2 2026: 211 institutions
Value heldQ1 2023: $376.6M
Q1 2021: $1.29BQ2 2021: $1.05BQ3 2021: $1.18BQ4 2021: $1.17BQ1 2022: $565.6MQ2 2022: $568.4MQ3 2022: $561.0MQ4 2022: $468.6MQ1 2023: $376.6MQ2 2023: $435.7MQ3 2023: $352.5MQ4 2023: $475.6MQ1 2024: $721.3MQ2 2024: $1.36BQ3 2024: $1.53BQ4 2024: $1.53BQ1 2025: $1.01BQ2 2025: $1.01BQ3 2025: $783.3MQ4 2025: $2.15BQ1 2026: $1.81BQ2 2026: $2.84B
Institutions holding NRIX and their total value by quarter
QuarterHoldersValue
Q2 2026211$2.84B
Q1 2026196$1.81B
Q4 2025182$2.15B
Q3 2025173$783.3M
Q2 2025164$1.01B
Q1 2025170$1.01B
Q4 2024175$1.53B
Q3 2024172$1.53B
Q2 2024174$1.36B
Q1 2024139$721.3M
Q4 2023131$475.6M
Q3 2023129$352.5M
Q2 2023126$435.7M
Q1 2023124$376.6M
Q4 2022119$468.6M
Q3 2022118$561.0M
Q2 2022106$568.4M
Q1 2022117$565.6M
Q4 2021125$1.17B
Q3 2021113$1.18B
Q2 2021104$1.05B
Q1 2021101$1.29B

Institutions, Q1 2023

Shares, value and share of portfolio for each institution holding Nurix Therapeutics, Inc.; share changes are against Q4 2022.

Institutions holding NRIX in Q1 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Bessemer Group Inc357,287$3.17M0.01%00.0%Unchanged
Charles Schwab Investment Management Inc384,840$3.42M0.00%+1,925+0.5%Added
Northern Trust Corp400,018$3.55M0.00%−7,925−1.9%Reduced
FMR LLC450,244$4.00M0.00%−553,399−55.1%Reduced
Millennium Management LLC461,592$4.10M0.00%−85,743−15.7%Reduced
Goldman Sachs Group Inc540,710$4.80M0.00%−80,938−13.0%Reduced
DAFNA Capital Management LLC566,695$5.03M1.51%00.0%Unchanged
Bank of America Corp631,204$5.61M0.00%−90,335−12.5%Reduced
Dimensional Fund Advisors LP633,517$5.63M0.00%+49,775+8.5%Added
Nuveen Asset Management, LLC669,973$5.95M0.00%−20,392−3.0%Reduced
Candriam Luxembourg S.C.A.900,088$7.36M0.05%+49,513+5.8%Added
Geode Capital Management, LLC930,691$8.26M0.00%+36,475+4.1%Added
Pictet Asset Management SA1,064,838$9.46M0.01%+102,481+10.6%Added
Boxer Capital, LLC1,224,892$10.9M0.53%00.0%Unchanged
Bain Capital Life Sciences Investors, LLC1,822,883$16.2M2.02%00.0%Unchanged
State Street Corp2,235,278$19.8M0.00%−272,709−10.9%Reduced
ARK Investment Management LLCSuperinvestorARK Invest2,239,859$19.9M0.14%+251,605+12.7%Added
Price T Rowe Associates Inc2,584,751$23.0M0.00%−668,985−20.6%Reduced
Vanguard Group Inc2,623,455$23.3M0.00%+420,850+19.1%Added
Redmile Group, LLC2,749,384$24.4M1.06%−251,400−8.4%Reduced
Deep Track Capital, LP2,997,830$26.6M1.13%+731,261+32.3%Added
Wasatch Advisors Inc3,174,002$28.2M0.18%+635,370+25.0%Added
Baker Bros. Advisors LP3,882,125$34.5M0.19%00.0%Unchanged
BlackRock Inc.4,291,140$38.1M0.00%+148,612+3.6%Added
T. Rowe Price Investment Management, Inc.0$00.00%−432,161−100.0%Sold out
Jackson Creek Investment Advisors LLC0$00.00%−49,662−100.0%Sold out
TD Asset Management Inc0$00.00%−43,259−100.0%Sold out
Jane Street Group, LLC0$00.00%−14,033−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−11,179−100.0%Sold out
Alpine Global Management, LLC0$00.00%−10,989−100.0%Sold out
XTX Topco Ltd0$00.00%−10,795−100.0%Sold out
Denali Advisors LLC0$00.00%−5,900−100.0%Sold out
Nisa Investment Advisors, LLC0$00.00%−2,250−100.0%Sold out
Rockefeller Capital Management L.P.0$00.00%−385−100.0%Sold out
Quantbot Technologies LP0$00.00%−319−100.0%Sold out
Leelyn Smith, LLC0$00.00%−200−100.0%Sold out
Simplex Trading, LLC0$00.00%−100−100.0%Sold out